Bailard »

Trevi Therapeutics shares owned by Bailard

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Bailard

Quarter filed Position value Share count Share price at filing
2024-03-31 $141k 41k 3.45
2023-03-31 $39k 21k 1.85
2022-12-31 $41k 21k 1.93

More positions owned by Bailard

Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Msci Eafe Etf (EFA)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Rus 2000 Val Etf (IWN)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard World Inf Tech Etf (VGT)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Gilead Sciences (GILD)
Amazon (AMZN)
Visa Com Cl A (V)

View all positions for Bailard

Top funds holding Trevi Therapeutics

NEA Management Company
Frazier Life Sciences Management
Rubric Capital Management
Viking Global Investors
VR Adviser
Opaleye Management
BlackRock
Vanguard Group
Logos Global Management
MPM Oncology Impact Management
MAI Wealth Advisors
Rosalind Advisors
Geode Capital Management
Landscape Capital Management
Checkpoint Capital

View all funds holding Trevi Therapeutics